ERBB3 and cancer: Furthermore, the higher serum level of HER-3/ErbB345, lower level of HER-246, and changes in the levels of IGFBPs47 and vascular endothelial growth factor receptors (VEGFRs)48 in OC users may provide insight into their differential risks for certain cancers.